AMENDMENT NO. 3 TO CONSULTING AGREEMENTConsulting Agreement • March 1st, 2022 • Agenus Inc • Biological products, (no disgnostic substances)
This AMENDMENT NO. 3 TO CONSULTING AGREEMENT (this “Amendment”) is entered into as of January 31, 2022 (the “Amendment Effective Date”), by and between Agenus Inc., a Delaware corporation having an address at 3 Forbes Road, Lexington, MA 02421 (“Agenus”), and Evan D. Kearns, an individual with an address at 40 Edgewater Lane, Needham, MA 02492 (“Consultant”) (each a “Party” and together the “Parties”). Capitalized terms used in this Amendment and not otherwise defined herein shall have those meanings attributed to them in the Agreement (as defined below).
AMENDMENT NO. 2 TO CONSULTING AGREEMENTConsulting Agreement • March 1st, 2022 • Agenus Inc • Biological products, (no disgnostic substances)
This AMENDMENT NO. 1 TO CONSULTING AGREEMENT (this “Amendment 2”) is entered into as of January 1, 2022 (hereinafter the “Amendment 2 Effective Date”), by and between Agenus Inc., a Delaware corporation having an address at 3 Forbes Road, Lexington, MA 02421, USA (the “Company”), and Brian Corvese (the “Consultant”) (each a “Party” and together the “Parties”). Capitalized terms used in this Amendment 2 and not otherwise defined herein shall have those meanings attributed to them in the Agreement (as defined below).
CONSULTING AGREEMENTConsulting Agreement • March 1st, 2022 • Agenus Inc • Biological products, (no disgnostic substances) • Massachusetts
This Consulting Agreement (this “Agreement”), effective as of April 30, 2021 (the “Effective Date”), is made by and between Agenus Inc., a Delaware corporation having an address at 3 Forbes Road, Lexington, MA 02421 (“Agenus”), and Evan D. Kearns, an individual having an address at 71 Emerson Road, Needham, MA 02492 (the “Consultant”) (each a “Party” and collectively the “Parties”).
